Keith Regnante, Chief Financial Officer at Wave Life Sciences Ltd. (WVE), sold 316 shares at $51.85 ($16K) on 2018-02-16, disclosed to the SEC on 2018-02-21.
Scheduled sale ($16k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| KROS | SELL | 2024-01-08 | $1.8M | — | Filing → |
| KROS | SELL | 2023-06-12 | $3.7M | — | Filing → |
| WVE | SELL | 2019-02-21 | $48K | — | Filing → |